Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 GBX | 0.00% | +10.29% | +20.00% |
Mar. 27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Mar. 27 | Allergy Therapeutics Gets OK to Draw Down GBP15 Million From Amended Loan Facility | MT |
Sales 2022 | 72.77M 91.85M | Sales 2023 | 59.59M 75.21M | Capitalization | 7.13M 9M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.41M | Net income 2023 | -43M -54.27M | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.6M | Net Debt 2023 | 21.14M 26.69M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 week | +9.09% | ||
Current month | +25.00% | ||
1 month | +22.45% | ||
3 months | +20.00% | ||
6 months | +87.50% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 09-06-30 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 22-03-31 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-06-05 | |
Peter Jensen
CHM | Chairman | 73 | 10-09-30 |
Mary Tavener
BRD | Director/Board Member | 62 | 19-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3 | 0.00% | 118 195 |
24-03-27 | 3 | +11.11% | 1,499,989 |
24-03-26 | 2.7 | -1.82% | 1,172,293 |
24-03-25 | 2.75 | 0.00% | 340,728 |
24-03-22 | 2.75 | 0.00% | 219 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+20.00% | 181M | |
+2.58% | 108B | |
+9.64% | 104B | |
+6.58% | 23.66B | |
-12.38% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.22% | 16.19B | |
+4.14% | 13.72B | |
+34.29% | 12.22B |